Evidence map›Paper›PMID 39438391›Full record

ArticleGeroScience2025

Divergent regulation of long non-coding RNAs H19 and PURPL affects cell senescence in human dermal fibroblasts.

Elena Frediani, Cecilia Anceschi, Jessica Ruzzolini, Sara Ristori, Alice Nerini, Anna Laurenzana, Anastasia Chillà, Claudia Elena Zoe Germiniani, Gabriella Fibbi, Mario Del Rosso and 5 more

Abstract read
In one paragraph

Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Elena FredianiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Cecilia AnceschiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Jessica RuzzoliniDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Sara RistoriDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Alice NeriniDepartment of Neurofarba (Department of Neurosciences, Drug Research and Child Health), University of Florence, Viale Pieraccini, 6 - 50139, Florence, Italy.
Anna LaurenzanaDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Anastasia ChillàDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Claudia Elena Zoe GerminianiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Via Vanvitelli, 32 - 20133, Milan, Italy.
Gabriella FibbiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Mario Del RossoDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Alessandra MocaliDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy.
Marco VenturinDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Via Vanvitelli, 32 - 20133, Milan, Italy.
Cristina BattagliaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Via Vanvitelli, 32 - 20133, Milan, Italy.
Lisa GiovannelliDepartment of Neurofarba (Department of Neurosciences, Drug Research and Child Health), University of Florence, Viale Pieraccini, 6 - 50139, Florence, Italy. lisa.giovannelli@unifi.it.
Francesca MargheriDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale G.B. Morgagni, 50 - 50134, Florence, Italy. francesca.margheri@unifi.it.ORCID 0000-0001-7122-6574

Funding

Associazione Italiana per la Ricerca sul Cancro FIBBIAIRCPiano di Sostegno alla Ricerca 2020 PSR2020_BATTAGLIA_LINEA_C to CBPiano di Sostegno alla Ricerca 2021 PSR2021_BATTAGLIA_LINEA_C to CBPiano di Sostegno alla Ricerca 2021 PSR2021_VENTURIN_LINEA_C to MVUniversità degli studi di Firenze -RICATEN 2021 RICATEN21Università degli Studi di Firenze -RICATEN 2021 RICATEN21Università degli Studi di Firenze -RICATEN 2022 RICATEN22
6 · The paper itself

Abstract

Cellular senescence is a permanent cell growth arrest that occurs in response to various intrinsic and extrinsic stimuli and is associated with cellular and molecular changes. Long non-coding RNAs (lncRNAs) are key regulators of cellular senescence by affecting the expression of many important genes involved in senescence-associated pathways and processes. Here, we evaluated a panel of lncRNAs associated with senescence for their differential expression between young and senescent human dermal fibroblasts (NHDFs) and studied the effect of a known senomorphic compound, resveratrol, on the expression of lncRNAs in senescent NHDFs. As markers of senescence, we evaluated cell growth, senescence-associated (SA)-β-Gal staining, and the expression of p21, Lamin B1 and γH2AX. We found that H19 and PURPL were the most altered lncRNAs in replicative, in doxorubicin (DOXO) and ionising radiation (IR)-induced senescence models. We then investigated the function of H19 and PURPL in cell senescence by siRNA-mediated silencing in young and senescent fibroblasts, respectively. Our results showed that H19 knockdown reduced cell viability and induced cell senescence and autophagy of NHDFs through the regulation of the PI3K/AKT/mTOR pathway; conversely, PURPL silencing reversed senescence by reducing (SA)-β-Gal staining, recovering cell proliferation with an increase of S-phase cells, and reducing the p53-dependent DNA damage response. Overall, our data highlighted the role of H19 and PURPL in the senescent phenotype and suggested that these lncRNAs may have important implications in senescence-related diseases.

Indexed as

Cellular SenescenceFibroblastsRNA, Long NoncodingAutophagyCell ProliferationCells, CulturedDoxorubicinHistonesHumansResveratrolDoxorubicinH19 long non-coding RNAHistonesResveratrolRNA, Long NoncodingCell senescenceH19Human fibroblastsLong non-coding RNAsPURPL

Identifiers

PMID39438391
PMCPMC11979041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.